首页 >>> 产品目录 >>> **学 >>> 一抗
仪表展览网 >>> 展馆展区 >>> 试剂 >>> **试剂 >>> ZIP Kinase抗体
> ZIP Kinase抗体

产品资料

ZIP Kinase抗体

ZIP Kinase抗体
  • 如果您对该产品感兴趣的话,可以
  • 产品名称:ZIP Kinase抗体
  • 产品型号:
  • 产品展商:XYbscience
  • 产品文档:无相关文档
简单介绍
ZIP Kinase抗体凋亡是由死亡域的适配器分子和蛋白酶的半胱天冬酶家族介导的。certainserine /苏氨酸蛋白激酶,如ASK1和RIP,是介质的细胞凋亡。*近发现了一种新的丝氨酸/苏氨酸激酶介导细胞凋亡,并被命名为拉链激酶。拉链激酶包含一个N端激酶结构域和C端的亮氨酸拉链结构和结合蛋白,是一个成员的ATF / crebfamily。ZIP Kinase抗体该激酶与磷酸转移酶(死亡相关蛋白激酶)具有高度同源性,是γ干扰素诱导细胞凋亡的中介。激酶过表达诱导细胞凋亡。磷酸激酶和磷酸二铵激酶是一种新的激酶家族,通过其催化活性介导细胞凋亡。信使RNA广泛表达于各种组织中。
产品描述
 

ZIP Kinase抗体ICC, IHC严格验证,品质保证.适用于多种种属反应性,被多篇文献引用并有用户反馈信息.确保特异性!产品具有以下特点:

1、全:网络全世界的上等产品,基本上各种抗体产品在该公司均能找到

2、新:产品及网站更新非常快,基本上每周均有新产品出现

3、优:产品质量好,投诉比较少

4、强:强大的技术支持队伍和力量,网站上有齐全的技术资料以及客户评论,并提供实时在线技术咨询,使您使用产品时没有任何后顾之忧。

产品编号xy-1692R

英文名称ZIP Kinase

中文名称凋亡相关蛋白激酶3抗体

别    名DAPK3; Death associated protein kinase 3; DAP kinase 3; DAP like kinase; Dapk 3; Dapk3; Death associated kinase 3; Death associated protein kinase 3; Dlk; EC 2.7.11.1; FLJ36473; ZIP; ZIP kinase; ZIPK; DAPK3_HUMAN.  

说 明 书100ul  200ul

研究领域染色质和核信号  信号转导  转录调节因子  

抗体来源Rabbit

克隆类型Polyclonal

ZIP Kinase抗体交叉反应 Human, Mouse, Rat, Chicken, Dog, Cow, Horse, Rabbit,

产品应用WB=1:500-2000 ELISA=1:500-1000 IHC-P=1:400-800 IHC-F=1:400-800 IF=1:100-500 (石蜡切片需做抗原修复)

not yet tested in other applications.

optimal dilutions/concentrations should be determined by the end user.

分 子 量52kDa

性    状Lyophilized or Liquid

浓    度1mg/1ml

免 疫 原KLH conjugated synthetic peptide derived from human DAPK3

亚    型IgG

纯化方法affinity purified by Protein A

储 存 液0.01M TBS(pH7.4) with 1% BSA, 0.03% Proclin300 and 50% Glycerol.

保存条件Store at -20 °C for one year. Avoid repeated freeze/thaw cycles. The lyophilized antibody is stable at room temperature for at least one month and for greater than a year when kept at -20°C. When reconstituted in sterile pH 7.4 0.01M PBS or diluent of antibody the antibody is stable for at least two weeks at 2-4 °C.

PubMedPubMed

产品介绍background:

Apoptosis is mediated by death domain containing adapter molecules and a caspase family of proteases. Certainserine/threonine protein kinases, such as ASK1 and RIP, are mediators of apoptosis. A novel serine/threonine kinase that mediates apoptosis was recently identified and designated ZIP kinase. ZIP kinase contains an N terminal kinase domain and a C terminal leucine zipper structure and binds to ATF4 that is a member of ATF/CREBfamily. ZIP kinase has high sequence homology to DAP kinase (death associated protein kinase), which is a mediator of apoptosis induced by gamma interferon. Overexpression of ZIP kinase induces apoptosis. ZIP and DAP kinases represent a novel kinase family, which mediates apoptosis through their catalytic activities. The messenger RNA was ubiquitously expressed in various tissues.


Function:

Serine/threonine kinase which is involved in the regulation of apoptosis, autophagy, transcription, translation, actin cytoskeleton reorganization, cell motility, smooth muscle contraction, and mitosis, particularly cytokinesis. Regulates both type I apoptotic and type II autophagic cell deaths signal, depending on the cellular setting. The former is caspase-dependent, while the latter is caspase-independent and is characterized by the accumulation of autophagic vesicles. Regulates myosin phosphorylation in both smooth muscle and non-muscle cells. In smooth muscle, regulates myosin either directly by phosphorylating MYL12B and MYL9 or through inhibition of smooth muscle myosin phosphatase (SMPP1M) via phosphorylation of PPP1R12A, and the inhibition of SMPP1M functions to enhance muscle responsiveness to Ca(2+) and promote a contractile state. Enhances transcription from AR-responsive promoters in a hormone- and kinase-dependent manner. Phosphorylates STAT3 and enhances its transcriptional activity. Positively regulates the canonical Wnt/beta-catenin signaling through interaction with NLK and TCF7L2. Can disrupt the NLK-TCF7L2 complex thereby influencing the phosphorylation of TCF7L2 by NLK. Phosphorylates histone H3 on 'Thr-11' at centromeres during mitosis. Involved in the formation of promyelocytic leukemia protein nuclear body (PML-NB), one of many subnuclear domains in the eukaryotic cell nucleus, and which is involved in oncogenesis and viral infection. Phosphorylates RPL13A on 'Ser-77' upon interferon-gamma activation which is causing RPL13A release from the ribosome, its association with the GAIT complex and its subsequent involvement in transcript-selective translation inhibition.

Isoform 2 can phosphorylate myosin, PPP1R12A and MYL12B.


Subunit:

Monomer and homotrimer. Can also exist as homodimer or form heterodimers with ATF4. Homodimerization is required for activation segment autophosphorylation Both interactions require an intact leucine zipper domain and oligomerization is required for full enzymatic activity. Also binds to DAXX and PAWR, possibly in a ternary complex which plays a role in caspase activation. According to PubMed:17953487, does not interact with PARW. Interacts with AATF, CDC5L, UBE2D1, UBE2D2 AND UBE2D3. Interacts with AR and this interaction is enhanced by AATF. Interacts (via leucine zipper) with TCP10L (via leucine zipper). Interacts (via kinase domain) with DAPK1 (via kinase domain). Interacts with STAT3, NLK and TCF7L2. Isoform 1 and isoform 2 can interact with myosin and PPP1R12A.


Subcellular Location:

Nucleus. Cytoplasm. Nucleus, PML body. Chromosome, centromere. Cytoplasm, cytoskeleton, centrosome. Note=The phosphorylated form is anchored in the cytoplasm and/or prevented from being shuttled to the nucleus, whereas nuclear translocation or retention is maximal when it is not phosphorylated. Phosphorylation at Thr-299 promotes cytoplasmic localization. Relocates to the cytoplasm on binding PAWR where the complex appears to interact with actin filaments. Localizes to promyelocytic leukemia protein nuclear bodies (PML-NBs). Associated: with the centrosomes throughout the mitotic cell cycle, with the centromeres from prophase to anaphase and with the contractile ring during cytokinesis.

Isoform 2: Nucleus. Cytoplasm.


Tissue Specificity:

Isoform 2 is expressed in the bladder smooth muscle.


Post-translational modifications:

Ubiquitinated. Ubiquitination mediated by the UBE2D3 E3 ligase does not lead to proteasomal degradation, but influences promyelocytic leukemia protein nuclear bodies (PML-NBs) formation in the nucleus.

The phosphorylation status is critical for: its intracellular localization, ability to oligomerize and its activity. The phosphorylated form is anchored in the cytoplasm and/or prevented from being shuttled to the nucleus, whereas nuclear translocation or retention is maximal when it is not phosphorylated. Phosphorylation increases the trimeric form, and its dephosphorylation shifts the equilibrium towards the monomeric form. Phosphorylation at Thr-180, Thr-225 and Thr-265 is essential for activity. Phosphorylation at Thr-299 promotes cytoplasmic localization. A species-specific loss of a key phosphorylation site in murine DAPK3 seems to direct it to the nucleus, while the presence of the Thr-299 site in human DAPK3 correlates with cytoplasmic localization. Both isoform 1 and isoform 2 can undergo autophosphorylation.


Similarity:

Belongs to the protein kinase superfamily. CAMK Ser/Thr protein kinase family. DAP kinase subfamily.

Contains 1 protein kinase domain.


Gene ID:

1613

抗体选择指南

ZIP Kinase抗体检测任何目的靶蛋白都有不止一种抗体可供选择,为缩小抗体的选择范围选中合适的抗体,需要考虑如下几种因素:

1 分析或应用的类型

2)样本蛋白的结构性质

3)样本的种属

4)抗体宿主的种类

5)抗体的标记和检测

1 分析试验的应用类型一般抗体说明书都列出该抗体经试验验证过适用于何种分析类型,如:

可以应用于WB IHC ICC ELASA 分析等,如果抗体说明书没有提及的应用类型,并不意味着该抗体不适用于此种分析应用类型,而仅是说明尚未经过此种分析试验验证,如果抗体不适用某些分析试验,则会在抗体说明书上标注出来不适于某分析试验。

2 样本蛋白的结构性质了解样本蛋白的结构性质有助于选择*合适的抗体,至少需要考虑两方面因素

(1)..待测样本蛋白的结构域:ZIP Kinase抗体是由各种不同**原**宿主而制备得来,其中的**原包括:全长蛋白、蛋白片断、多肽、全有机体(如:**)或细胞,抗体说明书一般都有**原的描述,如果打算检测的是蛋白片断或一种特殊的同型物或蛋白全长的某一区域,则必须选择用含此片段域的**原制备出的抗体。如果打算用FACS 流式检测活细胞的表面蛋白,则需要选择含该表面蛋白的胞外域来**制备的抗体。

(2)样本的提取或处理过程:某些抗体要求样本经过某些特殊处理,例如:许多抗体只识别还原和变性的、表位已暴露不受二级四级结构阻碍的蛋白样本,另一方面,某些抗体仅识别天然折叠状态的蛋白。

当选择**组化的抗体时,应注意某些抗体只识别未固定的冷冻的组织,而另一些抗体则适用于无需抗原修复解交联步聚的甲醛固定石蜡包埋的组织,这些都会在抗��说明书上应用部分标示出来 3 样本的物种 应选择物种相同或有交叉反应的抗体,抗体可能与不同物种的同种靶蛋白有交叉反应,因其氨基酸序列同源性较高。

如果样本的种类未列入抗体说明书上的交叉反应种属表中,并不意味着该抗体不适用于检测该物种的蛋白,而只是表示该物种尚未用此抗体检测验证过,应通过序列比对的方法来预测交叉反应,ZIP Kinase抗体可应用Expasy NCBI BLAST 来进行不同物种蛋白同源性比对。

4 一抗宿主物种的选择一般说来,在使用偶联二抗结合无偶联物的一抗时,一抗宿主动物的物种选择较为重要,对于**组化而言,尽可能选择与样本不同种系物种的一抗,从而避免二抗与样本内源性**球蛋白产生交叉反应,

例如:检测小鼠样本蛋白,则不应选择小鼠或大鼠源的一抗,*好选兔源的一抗,则二抗则可选择偶联了检测分子(酶、荧光素、生物素等)的抗兔IgG。如果选择有偶联物的一抗则不适用上述情况,除**组化外的其它对不含内源性**球蛋白样本的检测方法,则抗体宿主物种的影响不大,如对不含IgG 的细胞裂解物样本的western blotting检测。

尽管如此,ZIP Kinase抗体含有血清的组织裂解物和组织培养上清中含有**球蛋白,还原变性样本中含IgG,在western blot 检测中则结合出现IgG 分子50 and 25 kDa 的重链和轻链条带。

5 二抗的选择 二抗应选用与使用的一抗相同的物种来源,例如:如果你的一抗是小鼠的单克隆抗体,二抗则选抗小鼠的二抗anti-mouse secondary。建议检查二抗说明书确保该抗体适用于你的检测应用, 二抗一般连接荧光素FITC 或发光团。

6 双重染色抗体的选择用未偶联一抗进行细胞培养物或组织切片的双重**染色要求一抗来源于不同物种并且二抗分别识别其中之一,二抗说明书应描述其与其它物种来源的**球蛋有否有交叉吸附。

合格 合格 TRIM38 TRIM38蛋白抗体
合格 合格 ZP2 卵透明带糖蛋白2抗体
合格 ADAM2 去整合素样金属蛋白酶2抗体
合格 SLC26A6 溶质载体家族蛋白26成员6抗体
合格 TMEM120A 跨膜蛋白120A抗体
合格 合格 合格 CK5+CK6 细胞角蛋白5+6抗体
合格 PTPRN2 胰岛细胞自身抗原相关蛋白PTPRN2抗体
合格 SPINK13 丝氨酸蛋白酶抑制剂SPINK13抗体
合格 DcR1 肿瘤坏死因子配体超家族成员10C
合格 CCL27 皮肤T细胞虏获趋化因子抗体
合格 CYP4F3 细胞色素P450 F3抗体
合格 NHEDC1 钠/氢交换样结构域蛋白1抗体
合格 CENPQ 着丝粒蛋白Q抗体
合格 PYCR1 P5C还原酶1抗体
合格 CAIV/Carbonic Anhydrase IV 碳酸酐酶4抗体
合格 ZCCHC13 细胞核酸结合蛋白样抗体
合格 SLC19A1 溶质载体家族蛋白19成员A1抗体
合格 TSHR 促甲状腺素受体抗体
合格 SLC23A3 溶质载体家族蛋白23成员A3抗体
合格 IL28 Receptor alpha 白细胞介素28受体α抗体
合格 合格 sVEGFR2 可溶性血管内皮生长因子受体2抗体
合格 合格 P53(wt-p53) 野生型P53肿瘤抑制基因抗体
合格 合格 Integrin alpha 3 整合素α3抗体
合格 Integrin alpha 1 整合素α1抗体

产品留言
标题
联系人
联系电话
内容
验证码
点击换一张
注:1.可以使用快捷键Alt+S或Ctrl+Enter发送信息!
2.如有必要,请您留下您的详细联系方式!
  • 温馨提示:为规避购买风险,建议您在购买前务必确认供应商资质与产品质量。
  • 免责申明:以上内容为注册会员自行发布,若信息的真实性、合法性存在争议,平台将会监督协助处理,欢迎举报
产品留言
标题
内容
联系人
联系电话
电子邮件
公司名称
联系地址
验证码
点击换一张
注:1.可以使用快捷键Alt+S或Ctrl+Enter发送信息!
2.如有必要,请您留下您的详细联系方式!